Views & Analysis England’s ‘world-first’ cancer database – can it deliver on ... The world's first national database of cancer treatment outcomes has been launched in England.
Views & Analysis What doctors say about changes to the Cancer Drugs Fund Assessing HCPs’ social media comments about the new approach to cancer drug funding.
News Xalkori gains NICE approval after price cut NICE approval secured against background of renewed controversy
News NICE says no to liver cancer drug Nexavar Liver cancer treatment latest earmarked for removal from CDF
News Adcetris falls victim to NICE’s Cancer Drugs Fund clear-out More CDF legacy products likely to face same fate
Views & Analysis Saving the jewel in the crown of ‘UKplc’: Brexit's impact on... Pharma must embrace the opportunity to shape the UK’s political agenda in its favour.
News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
